Trident Lifeline Ltd (TLL) Fair Value & Analysis
Healthcare · IN · Market cap ₹3.1B
Strengths
Risks
Fair value as of: Aug 13, 2026
From 14 valuation models · updated 7 days ago
Fair value updated Aug 13, 2026, revised from ₹270.30 to ₹271.27 (+0.4%) since Jul 6, 2026. Share price +7.3% over the past month.
Below-average quality, currently priced close to our fair value.
What matters now
- The price sits close to our fair value, market and models broadly agree here, little valuation tension.
- Our model range runs from ₹189.70 (bear) to ₹339.08 (bull), base ₹271.27. The closer the price sits to the lower half, the larger the margin of safety.
- Quality 37/100 (below-average quality) with medium evidence: read the verdict with care.
Price vs Fair Value (4 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.
How to read this chart
46‑month range ₹108.15 – ₹334.00 · fair‑value band ₹189.70 – ₹339.08 · the ₹279.90 price screens above the ₹271.27 fair value. Dashed = 300-day average. As of Aug 13, 2026.
Analysis
Trident Lifeline Ltd (TLL) currently trades at ₹279.90, while our model-based Fair Value estimate is ₹271.27, implying the stock looks roughly 3.1% fairly valued today. The Quality Score stands at 37/100 (below-average quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: medium).
Over the trailing twelve months, Trident Lifeline Ltd generated revenue of ₹1.3B at a net margin of 14.8%. Revenue grew 5.1% year over year. It earns a return on equity of 21.8%. Net debt stands at ₹688M. Fundamentals as of Aug 13, 2026
Our scenario range runs from ₹189.70 (bear case) to ₹339.08 (bull case); at ₹279.90, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 15% below its 52-week high and 22% above its 52-week low, currently above its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -14% fair-value upside, at -3%, TLL screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 14 models by family
Widest divergence: Growth Earnings (₹741.36) versus Asset-Based (₹56.37). Highest evidence: ROIC Compounder (72).
Notify me when TLL reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 36 · Market factors (momentum, volatility) 53
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Trident Lifeline Limited, a pharmaceutical company, engages in the manufacture and marketing of finished dosages in India, Ghana, Kenya, Peru, Cameroon, Venezuela, and internationally.
Full company description
Trident Lifeline Limited, a pharmaceutical company, engages in the manufacture and marketing of finished dosages in India, Ghana, Kenya, Peru, Cameroon, Venezuela, and internationally. It offers pharmaceutical products in the form of tablets, capsules, liquid orals, external preparations, gel, mouthwash, and lotion; and nutraceutical tablets, capsules, liquids, sachets, oral sprays, and effervescent tablets, as well as ice gels, pastes, solutions, suspension, syrup, cream, drypowders, and toothpastes. The company was incorporated in 2014 and is based in Surat, India.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2022 – FY2026 · reported fiscal years
Trident Lifeline Ltd reported revenue of ₹1.3B in FY2026 versus ₹218M in FY2022, a compound +56.0%/yr. Reported net income was ₹190M in FY2026, compounding +48.2%/yr from FY2022.
Watch TLL: get an alert when its fair value changes →
Peer Group
Pharmaceutical Retailers · 63 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Pharmaceutical Retailers median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Pharmaceutical Retailers stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| JD Health International Inc 6618 | HK$38.86 | HK$33.31 | -14% |
| Alibaba Health Information Technology Limited 0241 | HK$3.26 | HK$2.04 | -37% |
| Raia Drogasil S.A RADL3 | R$18.00 | R$15.58 | -13% |
| Yifeng Pharmacy Chain Co 603939 | ¥24.03 | ¥29.07 | +21% |
| DaShenLin Pharmaceutical Group 603233 | ¥18.14 | ¥23.86 | +32% |
| Corporativo Fragua, S.A. FRAGUAB | 463.00 MXN | 726.02 MXN | +57% |
| MedPlus Health Services Limited MEDPLUS | ₹656.80 | ₹191.97 | -71% |
| LBX Pharmacy Chain Joint Stock Company 603883 | ¥13.44 | ¥10.57 | -21% |
| Yixintang Pharmaceutical Group 002727 | ¥12.29 | ¥9.45 | -23% |
| Anhui Huaren Health Pharmaceutical Co 301408 | ¥16.31 | ¥10.05 | -38% |
Compare Trident Lifeline Ltd with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Discover undervalued stocks
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Trident Lifeline Ltd (TLL) overvalued or undervalued?
What is the fair value of TLL?
What is the quality score of TLL?
What is the revenue of Trident Lifeline Ltd (TLL)?
What is the net profit margin of TLL?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Trident Lifeline Ltd and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.